FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2150998216> ?p ?o ?g. }

• W2150998216 endingPage "a386" @default.
• W2150998216 startingPage "a386" @default.
• W2150998216 abstract "To determine whether transdermal compared with oral use of hormone replacement therapy reduces the risk of gallbladder disease in postmenopausal women.Prospective cohort study (Million Women Study).Women registered with the National Health Service (NHS) in England and Scotland.1,001,391 postmenopausal women (mean age 56) recruited between 1996 and 2001 from NHS breast screening centres and followed by record linkage to routinely collected NHS hospital admission data for gallbladder disease.Adjusted relative risk and standardised incidence rates of hospital admission for gallbladder disease or cholecystectomy according to use of hormone replacement therapy.During follow-up 19 889 women were admitted for gallbladder disease; 17 190 (86%) had a cholecystectomy. Compared with never users of hormone replacement therapy, current users were more likely to be admitted for gallbladder disease (relative risk 1.64, 95% confidence interval 1.58 to 1.69) but risks were substantially lower with transdermal therapy than with oral therapy (relative risk 1.17, 1.10 to 1.24 v 1.74, 1.68 to 1.80; heterogeneity P<0.001). Among women using oral therapy, equine oestrogens were associated with a slightly greater risk of gallbladder disease than estradiol (relative risk 1.79, 1.72 to 1.87 v 1.62, 1.54 to 1.70; heterogeneity P<0.001) and higher doses of oestrogen increased the risk more than lower doses: for equine oestrogens >0.625 mg, 1.91 (1.78 to 2.04) v <or=0.625 mg, 1.76 (1.68 to 1.84); heterogeneity P=0.02; estradiol >1 mg, 1.68 (1.59 to 1.77) v <or=1 mg, 1.44 (1.31 to 1.59); heterogeneity P=0.003. The risk of gallbladder disease decreased with time since stopping therapy (trend P=0.004). Results were similar taking cholecystectomy as the outcome. Standardised hospital admission rates per 100 women over five years for cholecystectomy were 1.1 in never users, 1.3 with transdermal therapy, and 2.0 with oral therapy.Gallbladder disease is common in postmenopausal women and use of hormone replacement therapy increases the risk. Use of transdermal therapy rather than oral therapy over a five year period could avoid one cholecystectomy in every 140 users." @default.
• W2150998216 created "2016-06-24" @default.
• W2150998216 creator A5016466948 @default.
• W2150998216 creator A5053516882 @default.
• W2150998216 creator A5054898255 @default.
• W2150998216 creator A5055377175 @default.
• W2150998216 creator A5061926317 @default.
• W2150998216 creator A5075665094 @default.
• W2150998216 date "2008-07-10" @default.
• W2150998216 modified "2023-09-25" @default.
• W2150998216 title "Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study" @default.
• W2150998216 cites W111127352 @default.
• W2150998216 cites W1593442063 @default.
• W2150998216 cites W1682768769 @default.
• W2150998216 cites W1829438466 @default.
• W2150998216 cites W1964318461 @default.
• W2150998216 cites W1971370440 @default.
• W2150998216 cites W1972551448 @default.
• W2150998216 cites W1975369338 @default.
• W2150998216 cites W1978558581 @default.
• W2150998216 cites W2001896214 @default.
• W2150998216 cites W2005606528 @default.
• W2150998216 cites W2008484583 @default.
• W2150998216 cites W2023297148 @default.
• W2150998216 cites W2051881327 @default.
• W2150998216 cites W2052630556 @default.
• W2150998216 cites W2058507144 @default.
• W2150998216 cites W2076391725 @default.
• W2150998216 cites W2102336234 @default.
• W2150998216 cites W2107913761 @default.
• W2150998216 cites W2119278130 @default.
• W2150998216 cites W2123973543 @default.
• W2150998216 cites W2127332794 @default.
• W2150998216 cites W2162104193 @default.
• W2150998216 cites W2406884067 @default.
• W2150998216 cites W2415803583 @default.
• W2150998216 cites W2469416225 @default.
• W2150998216 cites W2515721699 @default.
• W2150998216 cites W3135185800 @default.
• W2150998216 cites W635314268 @default.
• W2150998216 cites W2588707937 @default.
• W2150998216 doi "https://doi.org/10.1136/bmj.a386" @default.
• W2150998216 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2500203" @default.
• W2150998216 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18617493" @default.
• W2150998216 hasPublicationYear "2008" @default.
• W2150998216 type Work @default.
• W2150998216 sameAs 2150998216 @default.
• W2150998216 citedByCount "72" @default.
• W2150998216 countsByYear W21509982162012 @default.
• W2150998216 countsByYear W21509982162013 @default.
• W2150998216 countsByYear W21509982162014 @default.
• W2150998216 countsByYear W21509982162015 @default.
• W2150998216 countsByYear W21509982162016 @default.
• W2150998216 countsByYear W21509982162017 @default.
• W2150998216 countsByYear W21509982162018 @default.
• W2150998216 countsByYear W21509982162019 @default.
• W2150998216 countsByYear W21509982162020 @default.
• W2150998216 countsByYear W21509982162021 @default.
• W2150998216 countsByYear W21509982162022 @default.
• W2150998216 countsByYear W21509982162023 @default.
• W2150998216 crossrefType "journal-article" @default.
• W2150998216 hasAuthorship W2150998216A5016466948 @default.
• W2150998216 hasAuthorship W2150998216A5053516882 @default.
• W2150998216 hasAuthorship W2150998216A5054898255 @default.
• W2150998216 hasAuthorship W2150998216A5055377175 @default.
• W2150998216 hasAuthorship W2150998216A5061926317 @default.
• W2150998216 hasAuthorship W2150998216A5075665094 @default.
• W2150998216 hasBestOaLocation W21509982161 @default.
• W2150998216 hasConcept C121608353 @default.
• W2150998216 hasConcept C126322002 @default.
• W2150998216 hasConcept C167704817 @default.
• W2150998216 hasConcept C188816634 @default.
• W2150998216 hasConcept C201903717 @default.
• W2150998216 hasConcept C2776493420 @default.
• W2150998216 hasConcept C2776641081 @default.
• W2150998216 hasConcept C2777148285 @default.
• W2150998216 hasConcept C2779279991 @default.
• W2150998216 hasConcept C2780159708 @default.
• W2150998216 hasConcept C2780275930 @default.
• W2150998216 hasConcept C2780354107 @default.
• W2150998216 hasConcept C29456083 @default.
• W2150998216 hasConcept C44249647 @default.
• W2150998216 hasConcept C530470458 @default.
• W2150998216 hasConcept C71924100 @default.
• W2150998216 hasConcept C72563966 @default.
• W2150998216 hasConcept C82789193 @default.
• W2150998216 hasConceptScore W2150998216C121608353 @default.
• W2150998216 hasConceptScore W2150998216C126322002 @default.
• W2150998216 hasConceptScore W2150998216C167704817 @default.
• W2150998216 hasConceptScore W2150998216C188816634 @default.
• W2150998216 hasConceptScore W2150998216C201903717 @default.
• W2150998216 hasConceptScore W2150998216C2776493420 @default.
• W2150998216 hasConceptScore W2150998216C2776641081 @default.
• W2150998216 hasConceptScore W2150998216C2777148285 @default.
• W2150998216 hasConceptScore W2150998216C2779279991 @default.
• W2150998216 hasConceptScore W2150998216C2780159708 @default.
• W2150998216 hasConceptScore W2150998216C2780275930 @default.
• W2150998216 hasConceptScore W2150998216C2780354107 @default.

• next